Calocurb starter and maintenance coming soon product shot
Qualifying orders must include 12 of Calocurb® CLINICAL Starter (SKU 721060) or Calocurb® CLINICAL Maintenance (SKU 722060) to receive 2 free of the same SKU. See additional promo details below.
BUY 12 BOXES, GET 2 FREE*
USE PROMO CODE: CALO25
BUY 12 BOXES, GET 2 FREE* USE PROMO CODE: CALO25

Science Meets Self-Control

Clinically Shown to Reduce Cravings by 40%1

Calocurb Capsule Image 1
Calocurb Stock1

Clinically Studied.
Naturally Effective.

Calocurb® CLINICAL features Amarasate®, a natural extract of New Zealand bitter hops that has been clinically researched to stimulate GLP-1, CCK and PYY release, resulting in reduced cravings, hunger and caloric intake.

6X
increase in
baseline GLP-12
40%
Decrease in cravings1
30%
Decrease in hunger1
18%
Reduced calorie intake2

The Science Behind Appetite Control

Natural GLP-1 Activation

Targeted Delivery

Amarasate® is delivered via a delayed-release capsule to the intestines, where it activates bitter taste receptors on enteroendocrine cells.

Gut Peptide Activation

Bitter taste receptor stimulation significantly increases appetite and craving suppressing GLP-1, CCK and PYY.

Fast Results That Last

Concentrated Amarasate® works within one hour with results that last up to six hours.

*Cannot be combined with any other offer, promotion or discount. Applies to Ortho Molecular Products brand only. Qualifying orders must include 12 of Calocurb® CLINICAL Starter (SKU 721060) or Calocurb® CLINICAL Maintenance (SKU 722060) to receive 2 free of the same SKU. Excludes Private Label orders. Offer expires 12/31/2025.
1. Walker E, Lo K, Gopal P. Gastrointestinal delivery of bitter hops extract reduces appetite and food cravings in healthy adult women undergoing acute fasting. Obes Pillars 2024;11:100117.
2. Walker EG, Lo KR, Pahl MC, et al. An extract of hops (Humulus lupulus L.) modulates gut peptide hormone secretion and reduces energy intake in healthy-weight men: a randomized, crossover clinical trial. Am J Clin Nutr 2022;115(3):925-940.
©  Ortho Molecular Products

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
In compliance with Health Plan Cost Transparency click here to access our health plan’s cost data files.